Cargando…
Measurement of Δ(9)THC and metabolites in the brain and peripheral tissues after intranasal instillation of a nanoformulation
BACKGROUND: Comparative bioavailability of cannabinoids following their administration by dosing routes has been studied previously, but there are no quantitative reports of distribution of Δ(9)THC, nor its metabolites, across various brain regions following intranasal (i.n.) administration. The aim...
Autores principales: | Upadhyay, Gunjan, Fihurka, Oksana, Habecker, Connor, Patel, Pranav, Sanchez-Ramos, Juan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9903512/ https://www.ncbi.nlm.nih.gov/pubmed/36750917 http://dx.doi.org/10.1186/s42238-022-00171-8 |
Ejemplares similares
-
Multi-Targeting Intranasal Nanoformulation as a Therapeutic for Alzheimer’s Disease
por: Fihurka, Oksana, et al.
Publicado: (2023) -
The Memory Benefit to Aged APP/PS1 Mice from Long-Term Intranasal Treatment of Low-Dose THC
por: Fihurka, Oksana, et al.
Publicado: (2022) -
Data on enrichment of chitosan nanoparticles for intranasal delivery of oligonucleotides to the brain
por: Sava, Vasyl, et al.
Publicado: (2020) -
Toxicogenetic analysis of Δ9-THC-metabolizing enzymes
por: Gasse, Angela, et al.
Publicado: (2020) -
Key Features in the Design and Function of Nanocarriers for Intranasal Administration of Gene Therapy in Huntington Disease
por: Fihurka, Oksana, et al.
Publicado: (2023)